TherapeuticsMD (TXMD) Capital Expenditures Growth (3y) (2014 - 2023)
TherapeuticsMD (TXMD) Capital Expenditures Growth (3y) (2014 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -4.39% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -11.01% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -0.22% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 34.19% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -8.00% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 4.68% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -7.72% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | TherapeuticsMD | 23.54 Mn | 14.35 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 139.61% |
| Sep 30, 2023 | -285.89% |
| Jun 30, 2023 | -361.98% |
| Mar 31, 2023 | -3.28% |
| Dec 31, 2022 | 176.41% |
| Jun 30, 2022 | -26.52% |
| Mar 31, 2022 | -45.71% |
| Sep 30, 2021 | -75.46% |
| Jun 30, 2021 | 29.65% |
| Mar 31, 2021 | 32.79% |
| Dec 31, 2020 | 86.33% |
| Jun 30, 2020 | -14.55% |
| Mar 31, 2020 | -8.96% |
| Dec 31, 2019 | 59.75% |
| Sep 30, 2019 | 185.86% |
| Jun 30, 2019 | 63.32% |
| Mar 31, 2019 | 52.17% |
| Dec 31, 2018 | 0.23% |
| Jun 30, 2017 | 3.31% |
| Mar 31, 2017 | 5.52% |